Effects of vatinoxan in dogs premedicated with medetomidine and butorphanol followed by sevoflurane anaesthesia: a randomized clinical study

Autor: Kati M. Salla, Heta A. Turunen, Ira J. Kallio-Kujala, Vuokko Pekkola, Daniela C. Casoni, Jaan Lepajoe, Pia Björkenheim, Marja R. Raekallio, Outi Vainio
Přispěvatelé: Equine and Small Animal Medicine, Doctoral Programme in Clinical Veterinary Medicine, Small Animal Hospital, Departments of Faculty of Veterinary Medicine, Helsinki One Health (HOH), Teachers' Academy, DAPHNE - Developing Assessment Practices in Higher Education, Marja Raekallio / Principal Investigator, Outi Vainio / Principal Investigator, Research Centre for Animal Welfare, Doctoral Programme Brain & Mind, Doctoral Programme in Drug Research
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Salla, Kati M; Turunen, Heta A; Kallio-Kujala, Ira J; Pekkola, Vuokko; Casoni, Daniela C; Lepajoe, Jaan; Björkenheim, Pia; Raekallio, Marja R; Vainio, Outi (2022). Effects of vatinoxan in dogs premedicated with medetomidine and butorphanol followed by sevoflurane anaesthesia: a randomized clinical study. Veterinary anaesthesia and analgesia, 49(6), pp. 563-571. Elsevier 10.1016/j.vaa.2022.08.002
Popis: Publisher Copyright: © 2022 The Author(s) Objective: To investigate effects of vatinoxan in dogs, when administered as intravenous (IV) premedication with medetomidine and butorphanol before anaesthesia for surgical castration. Study design: A randomized, controlled, blinded, clinical trial. Animals: A total of 28 client-owned dogs. Methods: Dogs were premedicated with medetomidine (0.125 mg m−2) and butorphanol (0.2 mg kg−1) (group MB; n = 14), or medetomidine (0.25 mg m−2), butorphanol (0.2 mg kg−1) and vatinoxan (5 mg m−2) (group MB-VATI; n = 14). Anaesthesia was induced 15 minutes later with propofol and maintained with sevoflurane in oxygen (targeting 1.3%). Before surgical incision, lidocaine (2 mg kg−1) was injected intratesticularly. At the end of the procedure, meloxicam (0.2 mg kg−1) was administered IV. The level of sedation, the qualities of induction, intubation and recovery, and Glasgow Composite Pain Scale short form (GCPS-SF) were assessed. Heart rate (HR), respiratory rate (fR), mean arterial pressure (MAP), end-tidal concentration of sevoflurane (FE′Sevo) and carbon dioxide (PE′CO2) were recorded. Blood samples were collected at 10 and 30 minutes after premedication for plasma medetomidine and butorphanol concentrations. Results: At the beginning of surgery, HR was 61 ± 16 and 93 ± 23 beats minute−1 (p = 0.001), and MAP was 78 ± 7 and 56 ± 7 mmHg (p = 0.001) in MB and MB-VATI groups, respectively. No differences were detected in fR, PE′CO2, FE′Sevo, the level of sedation, the qualities of induction, intubation and recovery, or in GCPS-SF. Plasma medetomidine concentrations were higher in group MB-VATI than in MB at 10 minutes (p = 0.002) and 30 minutes (p = 0.0001). Plasma butorphanol concentrations were not different between groups. Conclusions and clinical relevance: In group MB, HR was significantly lower than in group MB-VATI. Hypotension detected in group MB-VATI during sevoflurane anaesthesia was clinically the most significant difference between groups.
Databáze: OpenAIRE